Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2025-12-25 @ 3:16 AM
NCT ID:
NCT00202605
Eligibility Criteria:
Inclusion Criteria:
* Primary diagnosis of ADHD using DSM-IV-TR criteria (at least 6 of the 9 subtype criteria met)
* Baseline ADHD-RS-IV score =\>24
* IQ score of =\> 80 (using Kaufman Brief Intelligence Test)
Exclusion Criteria:
* BMI \< 18.5 or \> 30 kg/m2
* Diagnosis of Post Traumatic Stress Disorder, psychosis, bipolar illness, severe obsessive compulsive disorder, severe depressive or severe anxiety disorder
* History of seizure disorder or a lifetime history of any seizures (other than infantile febrile seizures), any tic disorder, or a current diagnosis and/or family history of Tourette's Disorder
* History of uncontrolled hypertension or currently hypertensive
* Subjects who have taken atomoxetine (STRATTERA) within 30 days prior to screening
* Current (or history within the last 12 months) of drug dependence or substance abuse disorder according to DSM-IV-TR criteria (excluding nicotine)
* Female subject is pregnant or lactating, less than 3 months post partum
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00202605
Study Brief:
Protocol Section:
NCT00202605